Cancer and Control of Genomic Integrity (CANGENIN)

The main objective of CANGENIN is to advance our knowledge on mechanisms that protect healthy cells from transforming into cancer cells by establishing a network with research groups in the fields of genomic integrity, transcriptional control and cancer epigenetics.   

NEWS:

• STSMs (Short-Term Scientific Missions /exchange visits)  
  All STSMs should be completed by May 20th, 2012.
  

• The Final Conference of CANGENIN was organized in Barcelona, Spain, April 15th-17th, 2012.
  
  
• The 7th MC meeting was held in the morning of April 17th, 2012 during the final conference in Barcelona.

Group picture from the 4th Annual Meeting on Cancer and Control of Genomic Integrity
in Zandvoort, 30th September –  2nd October, 2011.